European Institute of Science AB Logo

European Institute of Science AB

Manufactures diagnostic assays and point-of-care instruments for the veterinary health market.

EURI B | SPGR

Overview

Corporate Details

ISIN(s):
SE0020357440 (+1 more)
LEI:
549300VADF7E2RMTRE02
Country:
Sweden
Address:
Ideongatan 1A, 223 70 Lund
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

European Institute of Science AB is a manufacturer of diagnostic assays and point-of-care (POC) instrumentation, with a primary focus on the veterinary health market. The company develops, produces, and sells solutions for canine, feline, and equine diagnostics, targeting veterinary professionals in clinical laboratories and POC settings. Key products include the TurboReader™, a compact nephelometric diagnostic reader, and a portfolio of rapid in-vitro assays for monitoring inflammation and other health conditions. The company also distributes third-party veterinary products in Scandinavia. Founded in 1990, it has a history as a research and development hub that has successfully spun off multiple public med-tech and biotech companies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2009-10-03 20:01
Major Shareholding Notification
English 33.4 KB
2009-02-11 11:09
Annual / Quarterly Financial Statement
Swedish 323.6 KB
2009-02-02 14:29
Delisting Announcement
Swedish 255.8 KB
2008-10-31 09:45
Quarterly Report
Swedish 328.3 KB
2008-09-30 13:47
Regulatory News Service
Swedish 28.4 KB
2008-08-29 10:36
Interim Report
Swedish 322.1 KB
2008-06-30 08:05
Regulatory News Service
Swedish 259.1 KB
2008-05-16 15:08
Post-Annual General Meeting Information
Swedish 258.5 KB
2008-04-29 00:00
Annual Report
Swedish 687.0 KB
2008-04-18 12:45
Pre-Annual General Meeting Information
Swedish 45.8 KB
2008-04-14 09:22
Quarterly Report
Swedish 320.2 KB
2008-01-21 10:46
Earnings Release
Swedish 320.6 KB
2007-10-26 08:14
Quarterly Report
Swedish 322.1 KB
2007-10-16 10:47
Earnings Release
Swedish 257.6 KB
2007-08-31 11:52
Interim Report
Swedish 320.1 KB

Automate Your Workflow. Get a real-time feed of all European Institute of Science AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for European Institute of Science AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2024-11-27 Pharmart AB Other Sell 9,341 19,709.51 SEK

Peer Companies

Company Country Ticker View
MYUNGMOON PHARM CO.,LTD Logo
Develops, manufactures, and commercializes prescription & OTC medicines for global markets.
South Korea 017180
Nanexa AB Logo
Develops long-acting injectables using its proprietary nanotechnology for its own pipeline and partners.
Sweden NANEXA
Nanobiotix Logo
Develops a first-in-class radioenhancer to amplify radiotherapy's effect directly within tumors.
France NANO
Nanoform Finland OYJ Logo
Pharma tech firm engineering nanoparticles to enhance drug performance and development.
Finland NANOFH
NanoGroup S.A. Logo
Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.
Poland NNG
NanoRepro AG Logo
Develops and distributes rapid diagnostic self-tests for early disease detection.
Germany NN6
NATAC Logo
Develops sustainable plant extracts for nutraceutical, pharma, food, and animal nutrition industries.
Spain NAT
Biotech R&D of natural ingredients for health and wellness solutions.
South Korea 168330
Naturland Holding PLC Logo
A Hungarian company providing full-scale pharmaceutical manufacturing from R&D to sales.
United Kingdom NATUR
NeoImmuneTech, Inc. Logo
Develops NT-I7, a T cell-amplifying immunotherapy for cancer and infectious diseases.
United States of America 950220

Talk to a Data Expert

Have a question? We'll get back to you promptly.